Researchers affiliated with UTHealth Houston, competing under the team name Novamab AI, placed among the top five teams in ...

Creative Biolabs has expanded its preclinical support with tailored antibody discovery solutions for antibody-antibiotic conjugates.

Antibodies play a central role in your body’s immune defense. But they’re also nearly ubiquitous in biological research, ...

CAMBRIDGE, MA - - RushData connects gene synthesis, 1-day CHO expression, and high-throughput antibody assays in one workflow, returning structured experimental datasets for AI-driven discovery ...

Gator Bio, which focuses on biolayer interferometry (BLI) systems, and Hudson Lab Automation highlighted their integrated automation solution for high-throughput antibody discovery and ...

In many fields of endeavor, traditional techniques are being turbocharged by rapid, rational, computer-driven techniques—that is, by artificial intelligence (AI). And there is plenty of evidence that ...

SAN FRANCISCO, June 30, 2025--(BUSINESS WIRE)--Chai Discovery, which builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules, today announced a ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and ...

AWS reveals new AI drug discovery tool Amazon Bio Discovery removes the technical barriers to high computational AI experiments The tool can cut drug testing times significantly A new AI powered drug ...

A new report shows image manipulation in antibody validation data appears to be more widespread than previously thought.

A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists. The King's College London discovery, published today, could ...

Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most persistent challenges: lengthy timelines, high development costs and substantial ...